Redvax
M&A
STATUS
M&A
LATEST DEAL TYPE
Description
Operator of a biopharmaceutical company in Sweden. The company develops multi-component virus-like particles (VLPs) and other protein assemblies for vaccine development in the field of Cytomegalovirus (CMV).
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- Wagistrasse 23
- Schlieren
- 8952 Zurich
- Switzerland
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Redvax’s full profile, request a free trial.
Redvax Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 05-Jan-2015 | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC | Completed | Startup |
Redvax Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Redalpine Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 |